Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate after Denosumab in Osteoporosis (ZOLARMAB2)
NCT05655013Phase 4Active, not recruiting
- Sponsor
- Aarhus University Hospital
- Start
- May 2023
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronate in osteoporosis, sponsored by Aarhus University Hospital. Started May 2023; status: active, not recruiting.
02
Drugs
zoledronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05655013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05655013.